Gene Expression Profiles in Generalized Aggressive Periodontitis: A Gene Network-based Microarray Analysis

Sponsor
Kocaeli University (Other)
Overall Status
Completed
CT.gov ID
NCT02327533
Collaborator
(none)
60
21.9

Study Details

Study Description

Brief Summary

In this study, the investigators evaluated molecular biomarkers which play a role in the development of generalized aggressive periodontitis (GAgP) using gingival tissue samples through omics-based whole-genome transcriptomic while using healthy individuals as background controls.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Aggressive periodontitis (AgP) is an inflammatory periodontal disease which is complex, multifactorial, and destructive. Progression and severity of the disease depend on interacting risk factors such as: immunological, microbiological, environmental, and genetic factors, as well as age, sex, and race.Some patients are genetically predisposed to AgP; they have immunological abnormalities, which are thought to be under genetic control. However, high susceptibility for periodontal destruction and the relationship between inflammatory changes, and genetic factors remain unclear.

    Gene expression profiling is a powerful means of generating comprehensive genome-level data sets on diseases such as cancer, asthma, rheumatoid disorders and periodontitis, and provides significant insight information for these diseases. Gene expression profiling may provide an evidence for involving genes in the pathogenesis of AgP and generate further information other than clinical signs and symptoms of AgP.

    The aim of this study was to identify gene-expression patterns of patients with generalized aggressive periodontitis by whole-transcriptome gene-expression analyses.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    60 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Gene Expression Profiles in Generalized Aggressive Periodontitis: A Gene Network-based Microarray Analysis
    Study Start Date :
    Feb 1, 2013
    Actual Primary Completion Date :
    Sep 1, 2014
    Actual Study Completion Date :
    Dec 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    Patients with Aggressive Periodontitis

    The periodontal diagnosis of subjects with GAgP was established on the basis of clinical and radiographic criteria and was defined by the 1999 International World Workshop for a Classification of Periodontal Diseases and Conditions.(Lang et al., 1999)

    Controls

    Control subjects had no radiographic evidence of bone loss or any sign of past and present periodontitis.

    Outcome Measures

    Primary Outcome Measures

    1. mRNA quantification [2 months]

    Secondary Outcome Measures

    1. Definition of gen networking and new molecular pathways [2 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • The periodontal diagnosis of subjects with GAgP was established on the basis of clinical and radiographic criteria and was defined by the 1999 International World Workshop for a Classification of Periodontal Diseases and Conditions.(Lang et al.,
    1. Patients were included if they were between 18 and 35 years of age and otherwise healthy. The bone loss estimation was radiographically performed in each patient for the assessment of the extent and severity of alveolar bone loss.
    Exclusion Criteria:
    • Subjects were excluded if they had any known systemic diseases or conditions that can/could influence the periodontal status (cancer, cardiovascular and respiratory diseases), any history of hepatitis and/or HIV infection, immunosuppressive chemotherapy, current pregnancy, planning a pregnancy or lactation, requirement for antibiotic prophylaxis, oral diseases other than GAgP, ongoing orthodontic therapy, a history of antibiotic therapy, or periodontal treatment within the preceding six months.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Kocaeli University

    Investigators

    • Principal Investigator: Esra Güzeldemir-Akçakanat, DDS, PhD, Kocaeli University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Esra Guzeldemir-Akcakanat, DDS, PhD, Assoc. Prof., Kocaeli University
    ClinicalTrials.gov Identifier:
    NCT02327533
    Other Study ID Numbers:
    • KOU KAEK2013/15
    First Posted:
    Dec 30, 2014
    Last Update Posted:
    Dec 30, 2014
    Last Verified:
    Dec 1, 2014
    Keywords provided by Esra Guzeldemir-Akcakanat, DDS, PhD, Assoc. Prof., Kocaeli University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 30, 2014